Showing results (1421-1430 of 1,491) with videos related to

Sort By:
Pageof 150
Journal of Hepatology|August 12, 2009
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivoPippa Newell, Sara Toffanin, Augusto Villanueva, et al.
The Journal of Heredity|January 25, 2008
Maize centromere mapping: a comparison of physical and genetic strategiesRon J Okagaki, Morrison S Jacobs, Adrian O Stec, et al.
Cell Metabolism|February 27, 2025
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitisFanglin Ma, Miriam Longo, Marica Meroni, et al.
Cells|February 25, 2020
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic LiverGayane Hrachia Buniatian, Ralf Weiskirchen, Thomas S Weiss, et al.
Kidney International|December 24, 2010
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeDebbie S Gipson, Howard Trachtman, Frederick J Kaskel, et al.
Hepatology (Baltimore, Md.)|November 19, 2011
Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver diseaseLars P Bechmann, Amalia Gastaldelli, Diana Vetter, et al.
Hepatology (Baltimore, Md.)|October 27, 2025
Endothelial-to-mesenchymal transition: A targetable mechanism that contributes to portal vein thrombosis in cirrhosisAina Anton, Sarah Shalaby, María Luisa Botero, et al.
Gut|August 22, 2014
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deteriorationLindsay Y King, Claudia Canasto-Chibuque, Kara B Johnson, et al.
Scientific Reports|August 16, 2017
Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injurySvenja Sydor, Paul Manka, Jan Best, et al.
Pageof 150